Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary duodenal carcinoma

O A Adedeji1, C Trescoli-Serrano, M Garcia-Zarco

  • 1Kings Mill Hospital, Sutton-in-Ashfield, Nottinghamshire, UK.

Postgraduate Medical Journal
|June 1, 1995
PubMed
Summary

Primary duodenal carcinoma often presents at an advanced stage, posing diagnostic challenges and a poor prognosis. Early screening for familial adenomatous polyposis patients and aggressive treatment strategies are crucial for improving outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colorectal cancer in Nigeria: 40 years on. A review.

European journal of cancer care·2009
Same author

Recurrent megajejunum in an adult.

Journal of the Royal Society of Medicine·2002
Same author

Porcine dermal collagen graft in abdominal-wall reconstruction.

British journal of plastic surgery·2002
Same author

Recurrent hyponatremia associated with sertraline and lofepramine.

The American journal of psychiatry·1997
Same author

The trauma team--a system of initial trauma care.

Postgraduate medical journal·1996
Same author

Sertraline-induced agranulocytosis.

Postgraduate medical journal·1996

Area of Science:

  • Gastroenterology
  • Surgical Oncology

Background:

  • Primary duodenal carcinoma is rare, frequently diagnosed at advanced stages.
  • Majority of cases lack identifiable predisposing factors.
  • Increased risk observed in familial adenomatous polyposis (FAP) and duodenal adenomas.

Purpose of the Study:

  • To present eight cases of primary duodenal carcinoma.
  • To highlight diagnostic challenges and poor prognosis.
  • To emphasize the importance of screening and aggressive management.

Main Methods:

  • Retrospective case series analysis.
  • Review of clinical presentation, diagnosis, and treatment outcomes.
  • Literature review on risk factors and management strategies.

Main Results:

  • Cases presented with advanced disease, complicating diagnosis and treatment.
  • Familial adenomatous polyposis patients have a significantly increased risk (2% incidence, >50% of upper GI cancers in this group).
  • Duodenal villous adenomas have a 30-60% risk of carcinomatous change.

Conclusions:

  • Patients with FAP and duodenal adenomas require diligent screening and follow-up.
  • Aggressive surgical resection, even with advanced disease, improves outcomes.
  • Multimodal therapy including chemotherapy and radiotherapy enhances survival rates, with potential for 40-60% five-year survival.

Related Experiment Videos